A detailed history of American Century Companies Inc transactions in Pfizer Inc stock. As of the latest transaction made, American Century Companies Inc holds 3,057,712 shares of PFE stock, worth $85.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,057,712
Previous 3,121,581 2.05%
Holding current value
$85.6 Million
Previous $89.9 Million 5.58%
% of portfolio
0.05%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $1.65 Million - $1.9 Million
-63,869 Reduced 2.05%
3,057,712 $84.9 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $81.6 Million - $106 Million
3,121,581 New
3,121,581 $89.9 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $9.82 Million - $11.5 Million
-306,013 Reduced 8.32%
3,372,108 $112 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $13.7 Million - $15.9 Million
379,487 Added 11.5%
3,678,121 $135 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $75.4 Million - $98.2 Million
-1,915,362 Reduced 36.74%
3,298,634 $135 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $62.3 Million - $81.3 Million
1,491,342 Added 40.06%
5,213,996 $267 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $45 Million - $55 Million
1,029,069 Added 38.2%
3,722,654 $163 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $16.1 Million - $19.1 Million
345,697 Added 14.72%
2,693,585 $141 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $21.4 Million - $26.5 Million
-467,141 Reduced 16.59%
2,347,888 $122 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $11.4 Million - $17 Million
276,896 Added 10.91%
2,815,029 $166 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $66.3 Million - $85.1 Million
-1,688,022 Reduced 39.94%
2,538,133 $109 Million
Q2 2021

Aug 05, 2021

SELL
$35.91 - $40.68 $23.3 Million - $26.4 Million
-649,492 Reduced 13.32%
4,226,155 $165 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $46.6 Million - $52.6 Million
1,391,990 Added 39.96%
4,875,647 $177 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $115 Million - $147 Million
-3,444,497 Reduced 49.72%
3,483,657 $128 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $156 Million - $183 Million
-4,905,250 Reduced 41.45%
6,928,154 $254 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $2.32 Million - $2.81 Million
-77,029 Reduced 0.65%
11,833,404 $387 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $205 Million - $292 Million
-7,569,629 Reduced 38.86%
11,910,433 $389 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $165 Million - $187 Million
-5,014,741 Reduced 20.47%
19,480,062 $763 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $418 Million - $542 Million
12,867,424 Added 110.66%
24,494,803 $880 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $30.8 Million - $34.5 Million
-831,577 Reduced 6.67%
11,627,379 $504 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $50.4 Million - $55.4 Million
-1,344,285 Reduced 9.74%
12,458,956 $0
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $121 Million - $138 Million
-3,147,634 Reduced 18.57%
13,803,241 $603 Million
Q3 2018

Nov 02, 2018

SELL
$34.47 - $41.81 $107 Million - $130 Million
-3,100,881 Reduced 15.46%
16,950,875 $747 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $39.4 Million - $42 Million
-1,193,734 Reduced 5.62%
20,051,756 $727 Million
Q1 2018

May 03, 2018

SELL
$31.91 - $37.02 $41.3 Million - $47.9 Million
-1,294,398 Reduced 5.74%
21,245,490 $754 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $238 Million - $253 Million
7,161,892 Added 46.57%
22,539,888 $816 Million
Q3 2017

Nov 01, 2017

BUY
$31.0 - $34.15 $477 Million - $525 Million
15,377,996
15,377,996 $549 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.